Viewing Study NCT00694993


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2025-12-27 @ 11:17 PM
Study NCT ID: NCT00694993
Status: COMPLETED
Last Update Posted: 2017-08-10
First Post: 2008-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module